Intelligence Β· Patent portfolio

Regeneron Ireland Designated Patents

Full USPTO pharma patent portfolio for Regeneron Ireland Designated β€” grant dates, expiration, and drug cross-links.

Patents
8,292
Expiring ≀24m
426

Quick answer

Regeneron Ireland Designated has 8,292 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 426 expire within 24 months β€” use filters for patent-cliff planning.

Page 147 of 173

  1. US 6936599

    Estriol therapy for multiple sclerosis and other autoimmune diseases

    Expires Mon Aug 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  2. US 6936431

    Methods and compositions for inhibiting farnesyl transferase enzyme

    Expires Mon Aug 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  3. US 6936701

    Glycoconjugates and methods

    Expires Mon Aug 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  4. US 6933108

    Methods and compositions for use in the treatment of filovirus mediated disease conditions

    Expires Mon Aug 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  5. US 6933279

    Orally administered peptides to ameliorate atherosclerosis

    Expires Mon Aug 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  6. US 6933142

    HEC-G1CNAC6ST

    Expires Mon Aug 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  7. US 6929910

    Diagnostic and therapeutic methods using the H37 tumor suppressor gene

    Expires Mon Aug 11 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  8. US 6930085

    G-type peptides to ameliorate atherosclerosis

    Expires Mon Aug 11 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  9. US 6929802

    Method of cancer treatment

    Expires Mon Aug 11 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  10. US 6929811

    Monoamine oxidase (MAO) inhibitors and uses thereof

    Expires Mon Aug 11 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  11. US 6930101

    Thiazolopyrimidines useful as TNFΞ± inhibitors

    Expires Mon Aug 11 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  12. US 6929796

    Methods to treat undesirable immune responses

    Expires Mon Aug 11 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  13. US 6929799

    D-alanine racemase mutants of mycobacteria and uses therefore

    Expires Mon Aug 11 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  14. US 6930084

    Treating arthritis with TNF receptor releasing enzyme

    Expires Mon Aug 11 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  15. US 6927285

    Genes for human telomerase reverse transcriptase and telomerase variants

    Expires Mon Aug 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  16. US 6923973

    Peptide and DNA immunization against Coccidioides immitis infections

    Expires Mon Jul 28 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  17. US 6924095

    Retrovirus isolated from mantle histiocytes in mantle cell lymphoma

    Expires Mon Jul 28 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  18. US 6924118

    Recombinant intracellular pathogen immunogenic compositions and methods for use

    Expires Mon Jul 28 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  19. US 6924415

    Transgenic mice comprising a constitutively-activated MEK5 and exhibiting cardiac hypertrophy and dilated cardiomyopathy

    Expires Mon Jul 28 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  20. US 6921634

    Replication competent hepatitus C virus and methods of use

    Expires Mon Jul 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  21. US 6921664

    Telomerase

    Expires Mon Jul 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  22. US 6918927

    Coated implantable medical device

    Expires Mon Jul 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  23. US 6919425

    Isolation of a cell-specific internalizing peptide that infiltrates tumor tissue for targeted drug delivery

    Expires Mon Jul 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  24. US 6919072

    Methods and compositions for reducing collagen loss due to chronological aging in human skin

    Expires Mon Jul 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  25. US 6916802

    Amino ceramide-like compounds and therapeutic methods of use

    Expires Mon Jul 07 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  26. US 6916816

    Phenanthryl piperazinyl dicarboxylic acids as selective NMDA receptor modulating agents

    Expires Mon Jul 07 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  27. US 6913755

    Mutants of Streptococcal toxin A and methods of use

    Expires Mon Jun 30 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  28. US 6914050

    Stimulation of bone growth with thrombin peptide derivatives

    Expires Mon Jun 30 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  29. US 6911178

    Rh blood group antigen compositions and methods of use

    Expires Mon Jun 23 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  30. US 6911466

    AΞ²42 lowering agents

    Expires Mon Jun 23 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  31. US 6911471

    S-dimethylarsino-thiosuccinic acid s-dimethylarsino-2-thiobenzoic acid s-(dimethylarsino) glutathione as treatments for cancer

    Expires Mon Jun 23 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  32. US 6911324

    Induction of beta cell differentiation in human cells

    Expires Mon Jun 23 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  33. US 6911314

    Screening for drugs that affect TNF receptor releasing enzyme

    Expires Mon Jun 23 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  34. US 6911474

    Methods, compounds, and compositions for reducing body fat and modulating fatty acid metabolism

    Expires Mon Jun 23 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  35. US 6911532

    Vertebrate apoptosis gene: compositions and methods

    Expires Mon Jun 23 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  36. US 6908918

    Antitumor agents

    Expires Mon Jun 16 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  37. US 6908994

    Collagen-binding proteins from enterococcal bacteria

    Expires Mon Jun 16 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  38. US 6905873

    Recombinant p53 adenovirus methods and compositions

    Expires Mon Jun 09 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  39. US 6903076

    Antihelminthic anthraquinones and method of use thereof

    Expires Mon Jun 02 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  40. US 6902932

    Helically organized silk fibroin fiber bundles for matrices in tissue engineering

    Expires Mon Jun 02 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  41. US 6902933

    Surface transfection and expression procedure

    Expires Mon Jun 02 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  42. US 6903068

    Use of colostrinin, constituent peptides thereof, and analogs thereof for inducing cytokines

    Expires Mon Jun 02 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  43. US 6903135

    Methods and products related to 16-HETE analogs

    Expires Mon Jun 02 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  44. US 6902910

    Death domain containing receptor 4

    Expires Mon Jun 02 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  45. US 6902907

    Cystic fibrosis gene

    Expires Mon Jun 02 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  46. US 6899873

    Method of forming micro-tubular polymeric materials

    Expires Mon May 26 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  47. US 6899882

    Endothelial cell growth factor methods of isolation and expression

    Expires Mon May 26 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  48. US 6899895

    Lamellar gels and methods for making and regulating

    Expires Mon May 26 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many patents does Regeneron Ireland Designated have?

8,292 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Regeneron Ireland Designated patents expire?

426 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources Β· Patent directory